⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 6, 2026PharmacoEconomicsOpen Access

Component Clinical and Cost Outcomes Complementing Value of Information: Case Study of a Tuberculosis Diagnostics Clinical Trial

Pamela P. Pei Livia Qoshe Grady Florance A. Pandya Milton C. Weinstein Freedberg Ka A. David Paltiel Krishna Reddy

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research addresses the importance of evaluating both clinical and cost outcomes in the value of information (VOI) framework for tuberculosis diagnostics.
Conducted a clinical trial focusing on tuberculosis diagnostics.
Analyzed both aggregated net monetary benefit (NMB) and disaggregated clinical outcomes.
Evaluated cost savings alongside clinical effectiveness to inform decision-making.
Identified instances where positive NMB might hide unfavorable clinical outcomes.
Highlighted that aggregated VOI may not fully capture the impacts of diagnostics.
Suggested incorporating detailed outcomes in VOI studies for better prioritization.

Implication

Case study examines clinical outcomes and cost analysis in tuberculosis diagnostics, suggesting need for detailed evaluations.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pei et al. (2026) studied this question.

synapsesocial.com/papers/69ada885bc08abd80d5bb97f https://doi.org/10.1007/s40273-026-01595-3

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Value of Information for Clinical Trial Design: The Importance of Considering All Relevant Comparators2024 · 6 citations
2Implementation of a Value-Driven Outcomes Program to Identify High Variability in Clinical Costs and Outcomes and Association With Reduced Cost and Improved QualityDecision Analysis · 2016 · 284 citations
3A Pragmatic Bayesian Adaptive Trial Design Based on the Value of Information: The Value-Driven Adaptive DesignClinical Trial · 2026
4Protocol for the development of a Core Outcome Set (COS) for reporting outcomes of clinical trials of anti-tuberculosis treatment in adults with pulmonary tuberculosisHuman Clinical Trial · 2025 · 1 citations
5Cost-consequence analysis of diagnostic strategies for suspected community-acquired pneumonia in France and SpainCohort Study · 2026